愛爾眼科醫(yī)院集團

AIER Eye Hospital Group is China’s leading ophthalmology hospital group that covers Asia, Europe, and North America with huge scale and outstanding medical capacity. It has three listed companies in China (stock code: 300015) ，Europe (Spain: CBAV), and Southeast Asia (Singapore: 40T) with a total number of more than 600 specialized eye hospitals and centers and the annual outpatient visits in mainland China exceeded 10 million. Among those eye hospitals and centers, there are more than 500 in Mainland China, 7 in Hong Kong, 1 in the United States, more than 80 in Europe, and 12 in Southeast Asia. 愛爾眼科致力于引進和吸收國際同步的眼科技術(shù)與醫(yī)療管理理念，以專業(yè)化、規(guī)?；?、科學(xué)化為發(fā)展戰(zhàn)略，推動中國眼科醫(yī)療事業(yè)的發(fā)展。 AIER is committed to the parallel introduction and absorption of world-leading ophthalmic technology and management concept, with professionalism, scale and science as its strategy to advance China's ophthalmic medical care. 通過不斷的探索與實踐，并充分吸納國際先進的醫(yī)療管理經(jīng)驗的基礎(chǔ)上，成功探索出一套適應(yīng)中國國情和市場環(huán)境的眼科醫(yī)院連鎖經(jīng)營管理模式——“分級連鎖”。利用人才、技術(shù)和管理等方面的優(yōu)勢，通過全國各連鎖醫(yī)院優(yōu)良的診療質(zhì)量、優(yōu)質(zhì)的醫(yī)療服務(wù)和良好的醫(yī)患溝通，使愛爾眼科成為全國各地眼科患者信賴的眼科醫(yī)院。 Base on constant exploration and practice, also with absorbing advanced international medical management experience, AIER Eye Hospital Group has successfully established the "hierarchical chain" management model that adapts to China's market environment. Utilizing our advantages in talent, technology and management, we aim to provide the most trusted eye care to patients all over the country by offering good medical quality, superior medical service and harmonious doctors-to-patients communication. 2013年，愛爾眼科醫(yī)院集團與中南大學(xué)聯(lián)合成立專業(yè)的眼科醫(yī)學(xué)院——中南大學(xué)愛爾眼科學(xué)院，主要培養(yǎng)眼科碩、博士精英醫(yī)療人才，開啟了社會資本參與醫(yī)學(xué)教育的有益創(chuàng)新和探索; 2014年，與湖北科技大學(xué)聯(lián)合成立愛爾眼視光學(xué)院，旨在培養(yǎng)眼視光學(xué)的專業(yè)技術(shù)人才。 2019年，新增武漢大學(xué)愛爾眼科臨床學(xué)院及研究院。 與此同時，自2015年愛爾眼科先后成立愛爾眼科研究所、愛爾眼視光研究所、角膜病研究所、白內(nèi)障研究所、青光眼研究所、視網(wǎng)膜研究所和屈光研究所等7大研究所，旨在推動眼科學(xué)、視覺科學(xué)以及各亞專科前沿和臨床應(yīng)用技術(shù)的研究和創(chuàng)新。 愛爾眼科通過成立學(xué)院和研究所等機構(gòu)，正式打通了眼科的醫(yī)、學(xué)、研三大領(lǐng)域，使愛爾眼科的科研及臨床水平得到顯著提升，并以此推動中國眼科醫(yī)療事業(yè)的發(fā)展和進步。 In 2013, AIER and Central South University jointly set up AIER School of Ophthalmology, CSU, to educate and train medical professionals with advanced degrees，which opened a new era for social capital to be involved in medical education. In 2014, AIER joined the Hubei University of Science and Technology to establish the AIER School of Ophthalmology & Optometry, which aims to cultivate specialized talents in Optometry. In 2019, AIER Clinical College of Ophthalmology, and Ophthalmic Research Institute in Wuhan University were found. Besides, AIER has established 7 institutes since 2011, they are AIER Ophthalmology Institute, AIER Optometry Institute, AIER Refraction Institute, AIER Corneal Institute, AIER Glaucoma Institute, AIER Retinology Institute, and AIER Cataract Institute. At this point, AIER has bridged all three areas of medicine, education, and research, the establishment of these educational and research institutions will significantly boost our research and clinical standards. 在快速跨越式發(fā)展的過程中，愛爾眼科凝聚和培養(yǎng)了一批經(jīng)驗豐富、開拓創(chuàng)新的管理團隊和醫(yī)術(shù)精良、治學(xué)嚴(yán)謹(jǐn)?shù)难劭茖＜液歪t(yī)生團隊。截止2020年4月，愛爾眼科集團及旗下全球員工總數(shù) 36,000余人，其中眼科及視光醫(yī)生總數(shù)(含海外)7,400余人，包括一大批碩士生導(dǎo)師、博士生導(dǎo)師、博士、博士后、留學(xué)歐美的學(xué)者以及臨床經(jīng)驗豐富的核心專家，是中國眼科領(lǐng)域備受矚目的有生力量。 In the process of rapid development, AIER has gathered and cultivated a group of experienced and innovative management team and a team of ophthalmologists with excellent medical ability and rigorous academic background. As of April, 2020，AIER has more than 36,000 employees globally, including 7,400 ophthalmologists and optometrists. Ophthalmologists in AIER consist of a large number of Master's supervisor, PH.D supervisor, Ph.D, Post doctorates, scholars trained in Europe and the United States and core experts with rich clinical experience. They are a high-profile core force in the field of ophthalmology in China. 愛爾眼科的發(fā)展壯大，始終以“使所有人，無論貧窮富裕，都享有眼健康的權(quán)利”為使命，追求社會責(zé)任和自身發(fā)展的和諧統(tǒng)一，通過開創(chuàng)性的“交叉補貼”模式，一方面為患者提供更高品質(zhì)的眼科醫(yī)療服務(wù)，同時全面開展防盲治盲工作、投身社會公益和幫助弱勢群體，并聯(lián)合社會各界，推動整個中國防盲事業(yè)乃至國民眼健康事業(yè)的全面發(fā)展。 Since its founding, AIER always committed to the mission,“Enabling everyone, whether rich or poor, has the right to eye health.”With its "cross-subsidy" model, AIER provides patients with higher quality services, in the meantime dedicate itself to the social welfare and helping vulnerable groups to promote the cause of fighting blindness and national eye health. 隨著中國醫(yī)療衛(wèi)生體制改革的進一步推進，愛爾眼科順應(yīng)國家醫(yī)療衛(wèi)生政策和發(fā)展趨勢，適時在醫(yī)療行業(yè)推出“合伙人計劃”，致力于改變眼科醫(yī)生執(zhí)業(yè)的生態(tài)環(huán)境，最大限度地激發(fā)核心骨干的創(chuàng)造力和能動性，為推動公司規(guī)模與效益的同步提高注入持續(xù)發(fā)展的關(guān)鍵動力。愛爾眼科專注于眼科醫(yī)療服務(wù)事業(yè)，將在全國的城鄉(xiāng)縣域興建各級專業(yè)連鎖眼科醫(yī)院，為更多的人提供高質(zhì)量、多層次的眼科醫(yī)療服務(wù)。 With the reform on China's medical health system, AIER adapts to the national medical policy and trend, launching the "Partnership Program" in the healthcare industry to focus on changing the ecological environment for ophthalmologists and maximizing the creativity and initiative of core members in 2014. This strategy is a strong motivation for expanding AIER’s scale, raising benefits. AIER has always been focusing on eye care service and will establish more professional hospitals in smaller cities and counties providing high quality and multi-level eye care to more people.